Back to News
Latest News, Press Release

InteloMed, Inc. to Exhibit Non-Invasive Monitoring System for Assessing Dialysis Tolerance at the American Nephrology Nurses’ Association National Symposium

InteloMed’s CVInsight® Monitoring System will be demonstrated on site

 

PITTSBURGH, PA (April 27, 2016) – InteloMed, Inc., an emerging leader and developer of advanced non-invasive systems for patient monitoring and informatics, will be exhibiting the CVInsight® Patient Monitoring & Informatics System for assessing dialysis treatment tolerance at the American Nephrology Nurses Association (ANNA) 47th Annual National Symposium.  The ANNA National Symposium is one of the largest conferences of the year for individuals spanning the dialysis nursing spectrum, and other health care professionals at all levels of practice.  This year’s symposium is being held in Louisville, KY, May 1-4, 2016.

“The ANNA National Symposium is an important meeting for the dialysis nurse community, focusing on professional development and advances in technology for dialysis treatment.  The CVInsight® System is the first in a new category of advanced non-invasive monitoring options and provides unprecedented insight on the dialysis patient,” stated Jill Schiaparelli, InteloMed President and CEO.   “We are eager to share the clinical benefits of the technology with this important group of clinicians.”

Demonstrations of the CVInsight® Monitoring System will be available in the ANNA exhibit hall in the InteloMed booth, number 202.

 

About CVInsight® Patient Monitoring & Informatics System

Providing an unprecedented level of physiologic insight, the CVInsight® Monitoring System is an easy-to-use, multi-parameter system. It empowers clinicians with non-invasive, real-time, dynamic, and actionable information about a patient’s dialysis tolerance.  Based on patented and proprietary algorithms, the system provides clinician set alerts to notify healthcare providers of changes in the patient’s tolerance to dialysis treatment, allowing them to intervene to avoid dialysis interruptions that can have serious patient consequences.

The CVInsight® Patient Monitoring and Informatics System is FDA-cleared and CE-marked and has launched commercially.

 

About InteloMed

InteloMed is redefining the standard of care in patient monitoring and informatics through its intelligent, multi-dimensional, non-invasive CVInsight® Patient Monitoring & Informatics System.

The CVInsight® Patient Monitoring System provides real-time insights to inform clinical decisions in a variety of healthcare applications, including in-patient and out-patient facilities, clinics, medical facilities and sleep labs.

InteloMed is headquartered in Wexford, PA.

For more information, visit us at www.InteloMed.com.

 

About the American Nephrology Nurses Association

The mission of the American Nephrology Nurses Association (ANNA) is to promote excellence in and appreciation of nephrology nursing in an effort to make a positive difference for people with kidney disease.  Since it was established as a nonprofit organization in 1969, ANNA has been serving members who span the nephrology nursing spectrum. ANNA has a membership of over 10,000 registered nurses and other health care professionals at all levels of practice. Members work in such areas as conservative management, peritoneal dialysis, hemodialysis, continuous renal replacement therapies, transplantation, industry, and government/regulatory agencies.  For more information, visit: www.annanurse.org

 

Safe Harbor Statement

Certain statements in this release are “forward-looking” and as such are subject to numerous risks and uncertainties. Actual results may vary significantly from the results expressed or implied in such statements. Factors that could cause actual results to materially differ from forward-looking statements include, but are not limited to, the need to obtain additional capital in order to grow our business, our ability to engage qualified employees, the acceptance of new products by doctors and hospitals, changes in the regulatory environment and healthcare legislation, the need to keep pace with technological changes, our dependence on third party manufacturers to produce components of our technology platform on time and to our specifications, and the successful implementation of our commercial strategies.

 

CONTACT

 

InteloMed, Inc.

Michael Dignazio, CFO

Info@InteloMed.com

412.536.7654

 

PR / Media Contact:

Matthew Bird

President

1-800-PublicRelations, Inc.

646.401.4499

matt.bird@1800pr.com